Dalcetrapib seen topping list of Japanese-origin blockbusters
18 February 2010
Ian Haydock
Please Login to read the full article.
18 February 2010
Ian Haydock
ian.haydock@informa.com
Japan Tobacco's CETP inhibitor dalcetrapib (JTT-705) has moved to the top of a new list of predicted blockbuster drugs originating in Japan, helped by a global licensing deal with Roche and the discontinuation of Pfizer's same class molecule, torcetrapib, in late 2006.
Dalcetrapib, to which...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
